文献速递姑息放疗与转移瘤

预测接受姑息性放疗的疼痛性肿瘤患者的生存:基于三变量风险因素数模型的二次分析

Predicting the survival of patients with painful tumours treated with palliative radiotherapy: a secondary analysis using the 3-variable number-of-risk-factors model.
PubMed 文献 · Radiat Oncol · 2024-10-01

本研究为二次分析,纳入骨转移组485例和 miscellaneous painful tumours(MPT)组302例接受姑息性放疗的患者,按三变量NRF模型分组比较生存。骨转移组中位生存I、II、III组分别为35.1、10.1、3.3个月(P<0.001),MPT组分别为22.1、9.5、4.6个月(P<0.001)。NRF模型对两组生存预测均中等良好,C-index分别为0.689和0.625。

要点

  • 骨转移组485例,NRF模型I、II、III组中位生存分别为35.1、10.1、3.3个月(P<0.001)。
  • MPT组302例,NRF模型I、II、III组中位生存分别为22.1、9.5、4.6个月(P<0.001)。
  • 骨转移组C-index 0.689,MPT组0.625;校准曲线显示预测与观察生存合理一致。

核心结论

  • NRF模型在骨转移组和MPT组中对生存的预测均中等良好。

研究设计与样本

  • 本研究为对骨转移姑息性放疗研究和包含非骨转移肿瘤的 miscellaneous painful tumours(MPT)姑息性放疗研究的二次分析。
  • 共分析骨转移组485例和MPT组302例患者,按三变量NRF模型分组并比较组间生存。
  • 采用时间非依赖C-index和时间依赖AUROC评估区分度,并用校准曲线评估预测生存与观察生存的一致性。

主要发现

  • 骨转移组NRF模型I、II、III组中位生存时间分别为35.1、10.1、3.3个月(P<0.001)。
  • MPT组NRF模型I、II、III组中位生存时间分别为22.1、9.5、4.6个月(P<0.001)。
  • 骨转移组C-index为0.689,MPT组为0.625。
  • 骨转移组2至24个月的时间依赖AUROC范围为0.738至0.765,MPT组为0.650至0.689,两组均显示随时间一致的准确性。
  • 校准曲线显示预测生存与观察生存之间具有合理的一致性。

关键数值与推荐

  • 骨转移组中位生存:I组35.1个月、II组10.1个月、III组3.3个月(P<0.001)。
  • MPT组中位生存:I组22.1个月、II组9.5个月、III组4.6个月(P<0.001)。
  • 骨转移组C-index 0.689,MPT组C-index 0.625。
  • 骨转移组时间依赖AUROC 0.738至0.765(2至24个月),MPT组0.650至0.689。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 3-variable number-of-risk-factors (NRF) model is a prognostic tool for patients undergoing palliative radiotherapy (PRT). However, there is little research on the NRF model for patients with painful non-bone-metastasis tumours treated with PRT, and the efficacy of the NRF model in predicting survival is unclear to date. Therefore, we aimed to assess the prognostic accuracy of a 3-variable NRF model in patients undergoing PRT for bone and non- bone-metastasis tumours. METHODS: This was a secondary analysis of studies on PRT for bone-metastasis (BM) and PRT for miscellaneous painful tumours (MPTs), including non-BM tumours. Patients were grouped in the NRF model and survival was compared between groups. Discrimination was evaluated using a time-independent C-index and a time-dependent area under the receiver operating characteristic curve (AUROC). A calibration curve was used to assess the agreement between predicted and observed survival. RESULTS: We analysed 485 patients in the BM group and 302 patients in the MPT group. The median survival times in the BM group for groups I, II, and III were 35.1, 10.1, and 3.3 months, respectively (P < 0.001), while in the MPT group, they were 22.1, 9.5, and 4.6 months, respectively (P < 0.001). The C-index was 0.689 in the BM group and 0.625 in the MPT group. In the BM group, time-dependent AUROCs over 2 to 24 months ranged from 0.738 to 0.765, while in the MPT group, they ranged from 0.650 to 0.689, with both groups showing consistent accuracy over time. The calibration curve showed a reasonable agreement between the predicted and observed survival. CONCLUSIONS: The NRF model predicted survival moderately well in both the BM and MPT groups.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Sakurai T, Saito T, Yamaguchi K, et al. Predicting the survival of patients with painful tumours treated with palliative radiotherapy: a secondary analysis using the 3-variable number-of-risk-factors model. Radiat Oncol. 2024. PMID: 39354515. doi:10.1186/s13014-024-02503-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。